991 related articles for article (PubMed ID: 12771624)
1. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model.
Pallua N; von Heimburg D
Crit Care Med; 2003 May; 31(5):1490-4. PubMed ID: 12771623
[TBL] [Abstract][Full Text] [Related]
3. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma.
Campo S; Serlupi-Crescenzi O; Arseni B; Rossi S; Saggio I; Salone B; Cherubini G; Carminati P; De Santis R
Cytokine; 2005 Sep; 31(5):368-74. PubMed ID: 16061391
[TBL] [Abstract][Full Text] [Related]
4. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation.
Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A
Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
8. Burn injury and pulmonary sepsis: development of a clinically relevant model.
Davis KA; Santaniello JM; He LK; Muthu K; Sen S; Jones SB; Gamelli RL; Shankar R
J Trauma; 2004 Feb; 56(2):272-8. PubMed ID: 14960967
[TBL] [Abstract][Full Text] [Related]
9. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection.
Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER
Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919
[TBL] [Abstract][Full Text] [Related]
10. Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model.
Redl HR; Martin U; Khadem A; Pelinka LE; van Griensven M
Crit Care; 2005; 9(6):R735-44. PubMed ID: 16356222
[TBL] [Abstract][Full Text] [Related]
11. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
12. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
[TBL] [Abstract][Full Text] [Related]
13. [The different effects of glutamine on macrophage cytokines release in vivo and in vitro].
Wang XM; Liang MF; Yuan Y; Jiang W
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):456-60. PubMed ID: 18687170
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A.
Okiyama N; Sugihara T; Iwakura Y; Yokozeki H; Miyasaka N; Kohsaka H
Arthritis Rheum; 2009 Aug; 60(8):2505-12. PubMed ID: 19644888
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury: is it a new drug for modulation of systemic inflammatory response.
Eski M; Sahin I; Sengezer M; Serdar M; Ifran A
Burns; 2008 Feb; 34(1):104-8. PubMed ID: 17618052
[TBL] [Abstract][Full Text] [Related]
17. In vivo IL-18 supplementation ameliorates lethal acute lung injury in burn-primed endotoxemic mice: a novel anti-inflammatory role of IL-18.
Sekine K; Fujishima S; Sasaki J; Ishizaka A; Aiso S; Aikawa N
Shock; 2009 Nov; 32(5):554-62. PubMed ID: 19197224
[TBL] [Abstract][Full Text] [Related]
18. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of splenocyte interleukin-4 production after injury and lethal endotoxin challenge.
Napolitano LM; Campbell C; Bass BL
J Surg Res; 1997 Jan; 67(1):33-9. PubMed ID: 9070178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
